Translate
Altimmune Inc
About
Altimmune Inc (NASDAQ:ALT) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 5 2026
Altimmune Announces Fourth Quarter and Full-year 2025 Financial Results and Business Updates
Feb 26 2026
Altimmune to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 5, 2026
Jan 29 2026
Altimmune Announces Closing of $75 Million Registered Direct Offering of Common Stock
Jan 28 2026
Altimmune Announces Pricing of $75 Million Registered Direct Offering of Common Stock
Jan 5 2026
Altimmune Receives FDA Breakthrough Therapy Designation for Pemvidutide in MASH